Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 20Nasopharyngeal Carcinoma 8Lung Neoplasms 7Colorectal Neoplasms 4Melanoma 3Esophageal Squamous Cell Carcinoma 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Osteosarcoma 2Nasopharyngeal Neoplasms 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Esophageal Neoplasms 2Unresectable Non-small Cell Lung Cancer 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Recurrence 1Radiation Injuries 1Quality of Life 1Pleural Effusion, Malignant 1Non-squamous Non-small Cell Lung Cancer 1Neuroblastoma 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal 1Carcinoma, Hepatocellular 1Brain Neoplasms 1Bone Neoplasms 1Advanced Pancreatic Cancer 1

Interventions

Paclitaxel 9apatinib 8Capecitabine 7Oxaliplatin 6Cisplatin 5camrelizumab 4S 1 (combination) 4Fluorouracil 3Docetaxel 3130-nm albumin-bound paclitaxel 3titanium silicide 2Leucovorin 2vorolanib 1trifluridine tipiracil drug combination 1tipiracil 1spartalizumab 1rucaparib 1relatlimab 1raltitrexed 1pazopanib 1olaparib 1lobaplatin 1linrodostat 1endostar protein 1durvalumab 1dacomitinib 1capivasertib 1Trifluridine 1Sunitinib 1SHR-1701 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Gastric Cancer × endostar protein × Clear all
NCT00842491 2015-05-19

Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer

Peking University

Phase 2 Completed
45 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡